EUVIMEDEUVIMED entdecken
Crossref

Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis

Pascal Chavanet, Alice Matheux iD, Thibault Sixt iD, Jacques Barbet, Roland Nau iD, Pascal Guerard, Isabelle Fournel, Bruno Mourvillier, Mathieu Blot, Lionel Piroth iD

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkaf474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Pascal Chavanet und 9 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Infectiologie, CHU Dijon, Dijon 21000, France. Hauptthemen laut MEDLINE: Daptomycin, Meningitis, Pneumococcal, Anti-Bacterial Agents, Cerebrospinal Fluid. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Clinical Research Hospital Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

There are few data on the penetration of daptomycin into the cerebrospinal fluid (CSF) of patients with bacterial meningitis. This ancillary study of the AddaMap trial aimed to assess the CSF penetration of intravenous daptomycin in 13 patients with pneumococcal meningitis. Patients and methods Daptomycin was administered at 10 mg/kg/day to 13 patients with pneumococcal meningitis admitted to the Dijon University Hospital. Blood and CSF samples were collected on days 3 and 8. The population pharmacokinetics of daptomycin in plasma and CSF were studied using a two-compartment model.

Results

A large inter-individual variability in plasma areas under the curve (median, 25–75-percentile), 7843 h.mg/L (6606–9264), plasma peak, 107.5 mg/L (81.4–126.3) and trough 14 mg/L (7.6–19.3) concentrations and elimination half-lives, 8.8 hours (7.9–10.8), was observed. In CSF, the maximum concentration was 0.88 mg/L (0.57–2.82), and the elimination half-life was 23.8 hours (18.7–39.3). The AUC CSF/plasma ratio was 2.20% (1.7–2.3). Daptomycin CSF penetration was significantly correlated with CSF levels of proteins and lactate. CSF concentrations, 0.67 mg/L (0.39–0.86), were above the MIC90 of pneumococci resistant to beta-lactam. Simulations showed that a loading dose could reduce the time required to reach a biologically active concentration in CSF.

Conclusion

We conclude that daptomycin administered at a dose of 10 mg/kg/day achieves CSF concentrations that may exert non-lytic anti-pneumococcal effects and demonstrate significant activity against highly resistant pneumococcal strains. These findings suggest that daptomycin could be considered as a valuable adjunctive therapy in the treatment of pneumococcal meningitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaptomycinMeningitis, PneumococcalAnti-Bacterial AgentsCerebrospinal FluidHumansFemaleMiddle AgedAgedMaleAdultPlasmaAdministration, IntravenousStreptococcus pneumoniae

Substanzen

DaptomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Département d'Infectiologie, CHU Dijon, Dijon 21000, France.
  • Laboratoire de Pharmacologie Toxicologie, Plateforme de biologie Hospitalo-Universitaire, Dijon 21000, France.
  • GIP Arronax, Nantes Université, Nantes 44000, France.
  • Department of Neuropathology, University Medicine Göttingen, Georg-August-University Göttingen, Göttingen 37075, Germany.
  • Université Bourgogne Europe, CHU Dijon Bourgogne, Centre d'Investigation Clinique, module épidémiologie clinique, INSERM, CIC1432, Dijon 21000, France.
  • Médecine Intensive et réanimation polyvalente, CHU Reims, Reims 51100, France.

ORCID-Profile: Alice Matheux, Thibault Sixt, Roland Nau, Lionel Piroth

Förderung

  • Clinical Research Hospital Program

Zitieren

APA

Chavanet, P., Matheux, A., Sixt, T., Barbet, J., Nau, R., Guerard, P., Fournel, I., Mourvillier, B., Blot, M., & Piroth, L. (2026). Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf474

Vancouver

Chavanet P, Matheux A, Sixt T, Barbet J, Nau R, Guerard P, et al. Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkaf474

BibTeX
@article{Chavanet2026,
  author = {Chavanet, Pascal and Matheux, Alice and Sixt, Thibault and Barbet, Jacques and Nau, Roland and Guerard, Pascal and Fournel, Isabelle and Mourvillier, Bruno and Blot, Mathieu and Piroth, Lionel},
  title = {Penetration of daptomycin in cerebrospinal fluid during pneumococcal meningitis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkaf474}
}
Kostenlos starten →